1、 Development and validation of RP-HPLC method for simultaneous estimation of Ofloxacin and Ornidazole inpresence of Ornidazole Impurity in combined pharmaceutical dosage form 2、 Minerva Gastroenterol Dietol. 2015 Dec;61(4):273-92. Probiotics in digestive diseases: focus on Lactobacillus GG. Pace F1, Pace M, Quartarone G. 3、 El-Safory N S，F(xiàn)azary A E，Lee C-K. Hyaluronidases, a group of glycosidases: current and future perspectives[J]. Carbohydrate Polymers, 2010, 81(2): 165-181. 4、 Perng CK, Wang YJ, Tsi CH，et al. In vivo angiogenesis effect of porous collagen scaffold with hyaluronic acid oligosaccharides. J Surg Res，2011，168(1) : 9-15. 5、 Termeer C, Sleeman JP, Simon JC. Hyaluronan- magic glue for the regulation of the immune response [J]. Trends Immunol, 2003, 24(3):112- 114. 6、 https://www.eurekalert.org/pub_releases/2019-01/uob-bri010819.php 7、 Collection of Czechoslovak Chmical Communication, 1987, vol47, #1, P65-71. 8、 Phloroglucinol in irritable bowel syndrome 9、 Phosphodiesterase 5 inhibitors in male sexual dysfunction 10、 The Response to Vedolizumab in Chronic Granulomatous Disease   [更多]

和藥品原廠說(shuō)明書 屬性一致，形成EXECL文檔，一個(gè)藥品一行，屬性項(xiàng)就X軸排開，，   [更多]

標(biāo)題：重金求購(gòu)“DTaP/IPV”《 BP2015 》的藥典標(biāo)準(zhǔn)一份. 詳細(xì)要求： 需求名稱：Diphtheria, Tetanus, Pertussis (Acellular Component) and Inactivated Poliomyelitis Vaccine, Adsorbed的藥典標(biāo)準(zhǔn) 具體要求：英文原文電子版，最好有中文 要求時(shí)間：請(qǐng)?jiān)?019年1月22日之前 交稿方式：直接點(diǎn)擊交稿在線交稿就是了，我會(huì)每天過來(lái)看的，謝謝各位藥智的戰(zhàn)友們   [更多]

① 求購(gòu)云南省中藥 飲片標(biāo)準(zhǔn)/藥材標(biāo)準(zhǔn)/炮制規(guī)范 PDF版（價(jià)格為5元/篇）： 為云南省食藥監(jiān)局歷年通過發(fā)文補(bǔ)充的上述標(biāo)準(zhǔn)/規(guī)范，文件編號(hào)為云YNZYC-XXXX-XXXX-XXXX、云YPBZ-XXXX-XXXXX、云PZGF-XXXX-XXXX等格式的。 ②PDF文件要求：真實(shí)、無(wú)水印、完整、清晰，來(lái)源可靠（非網(wǎng)上百度所得）。 ② 若發(fā)現(xiàn)文件有誤或不完整，相應(yīng)扣除一定的賞金。 補(bǔ)充：目前已有云PZGF-0003-2018、云PZGF-0005-2018、云PZGF-0006-2018、云PZGF-0004-2018、云PZGF-0002-2016、云PZGF-0001-2016、云YPBZ-0209-2014、云YPBZ-0205-2014、云YNZYC-0363-2015-2017、云YNZYC-0329-2010-2016、云YPBZ-0214-2015、云PZGF-0007-2018   [更多]

求購(gòu)：USP Monographs: Temozolomide for Injection”《 USP41-NF36 》的美國(guó)藥典（USP41-NF36 ）標(biāo)準(zhǔn)一份   [更多]

求購(gòu)“USP Monographs: Teriparatide Injection”《 USP41-NF36 》的藥典標(biāo)準(zhǔn)一份.   [更多]

“Formulated Preparations: Specific Monographs: Inositol Nicotinate Tablets”《 BP2019 》的藥典標(biāo)準(zhǔn)一份.   [更多]

最好能附帶原料藥標(biāo)準(zhǔn)   [更多]

1、Zhurnal Prikladnoi Khimii (Sankt-Peterburg, Russian Federation), Volume: 9, Pages: 957-64(in English 964), Journal, 1936. 2、Chemicke Listy pro Vedu a Prumysl, Volume: 37, Pages: 289-90, Journal, 1943. 3、Fulvestrant--a novel estrogen receptor antagonist for the treatment of advanced breast cancer. 4. Drugs Today (Barc). 2018 Sep;54(9):519-533. doi: 10.1358/dot.2018.54.9.2776624. An update on tolvaptan for autosomal dominant polycystic kidney disease. Poch E1, Rodas L2, Blasco M2, Molina A2, Quintana L2. 5.Parameter optimization and process control for the sterilization of ornidazole and sodium chloride injection 6.Physical and pharmacotechnological studies of ornidazole drug 7. Analytical studies for the determination of ornidazole in the presence of degradation products By Visan, Veronica; Ionescu, Mariana S.; Dragos, Mariana; Belu, Dan; Cosofret, Vasile From Revistade Chimie (Bucharest, Romania) (1989), 40(8), 728-31. Language: Romanian, Database: CAPLUS 8. Reactions of nitroimidazoles with free radicals--enhancement of reaction by u.v. irradiation By Moore D E From International journal of radiation biology and related studies in physics, chemistry, and medicine (1985), 47(5),563-8, Language: English, Database: MEDLINE   [更多]

1. Miller J. Ogidigben, Teh-Ching Chu and David E. Potter. Naphazoline-induced neuroendocrine changes Increases in ANP and cGMP levels 2. Robert J. Dockhorn and Thomas G. Duckett. Comparison of Naphcon-A and Its components 3. Mark B, Abelson MD, Salim I, et al. Tolerance and absence of rebound vasodilation following topical ocular decongestant usage 4. Ogidigben MJ, Chu TC, Potter DE. Naphazoline-induced suppression of aqueous humor pressure and flowinvolvement of central and peripheral alpha(2) I(1) receptors 5. The efficacy of long-term treatment with Tolvaptan to prolong the time until dialysis initiation in patients with chronic kidney disease and heart failure 6. Renoprotective effects of tolvaptan in hypertensive heart failure rats depend on renal decongestion 7. Tolvaptan Efficiently Reduces Intracellular Fluid Working Toward a Potential Treatment Option for Cellular Edema 8. Analysis of tolvaptan non-responders and outcomes of tolvaptan treatment of ascites 9. Tolvaptan in Japanese patients with later-stage autosomal dominant polycystic kidney disease 10. Safety and Effectiveness of Tolvaptan Administration after Total Arch Replacement 11. Nephrol Dial Transplant. 2018 Oct 12. doi 10.1093ndtgfy297. [Epub ahead of print] 12. Nephrol Dial Transplant. 2018 Oct 11. doi 10.1093ndtgfy298. [Epub ahead of print] 13. Development and validation of RP-HPLC method for simultaneous estimation of Ofloxacin and Ornidazole inpresence of Ornidazole Impurity in combined pharmaceutical dosage form 14. Stability-indicating methods for the determination of Ornidazole in the presence of its degradate according to ICH guidelines 15. A sensitive HPLC method of determination of 2-methyl 5-nitro imidazole & reaction mass of intermediates of ornidazole in ornidazole bulk manufacturing 16. Development and validation of a reversed-phase HPLC method for the analysis of ornidazole in pharmaceutical dosage forms 17. On the hydrolytic behavior of tinidazole, metronidazole,   [更多]